|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$22,000
|
N/A
|
National Institutes of Health
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$666
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$834,152
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Childrens Oncology Group Statistics and Data Center
|
5U10CA180899-05
|
$7,738,106
|
$773,811
|
DEVIDAS, MEENAKSHI
|
UNIVERSITY OF FLORIDA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$64,202
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$250,739
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-39
|
$6,063,271
|
$181,898
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$428,228
|
Camphausen, Kevin
|
CCR (NCI)
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$421,876
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$178,096
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$174,656
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$900,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
$620,405
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$90,276
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$197,894
|
Gress, Ronald
|
CCR (NCI)
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,671,202
|
$250,680
|
Pastan, Ira
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,382,902
|
$691,451
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
5P01CA214091-02
|
$1,312,028
|
$301,766
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
DNA repair
|
ZIA BC 010283
|
$1,309,141
|
$222,554
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,096,433
|
$219,287
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Smartphone for molecular cancer diagnostic in Africa
|
4UH3CA202637-03
|
$973,275
|
$486,638
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
5R01CA206019-03
|
$802,716
|
$802,716
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
|
ZIA BC 010598
|
$785,837
|
$39,292
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$665,279
|
$66,528
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$641,445
|
$192,433
|
Jaffe, Elaine
|
CCR (NCI)
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
5U10CA180836-05
|
$634,699
|
$15,867
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors
|
5R01CA204258-02
|
$626,296
|
$87,681
|
NICHOLS, HAZEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$613,782
|
$122,756
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA
|
5R01CA215405-02
|
$603,556
|
$603,556
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Lymphoma Studies
|
ZIA SC 006741
|
$564,009
|
$112,802
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Lymphoma Disease Discovery and Definition
|
ZIA SC 000550
|
$561,264
|
$56,126
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation
|
5R01CA047006-31
|
$532,500
|
$266,250
|
ZHAO, BO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Hematopathology Fellowship
|
ZIE BC 011241
|
$400,903
|
$100,226
|
Jaffe, Elaine
|
CCR (NCI)
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
5R01CA213138-02
|
$395,738
|
$130,594
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
|
1R01CA232616-01
|
$381,507
|
$381,507
|
KENNEY, SHANNON
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Regulation of EBV Latency by EBNA1
|
2R01CA093606-16
|
$380,903
|
$304,722
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$379,286
|
$18,964
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
|
5R01CA161026-08
|
$373,399
|
$186,700
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
|
In Vivo Model of Epstein-Barr Virus Latency
|
5R01CA073507-20
|
$372,677
|
$186,339
|
LONGNECKER, RICHARD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$366,567
|
$91,642
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$364,078
|
$72,816
|
Rose, Jeremy
|
CCR (NCI)
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$364,078
|
$72,816
|
Rose, Jeremy
|
CCR (NCI)
|
|
Regulation of transcription and tumor suppression by MTG family members
|
5R01CA178030-05
|
$364,000
|
$120,120
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
Mechanisms of transcription factor integration at the c-myc promoter
|
ZIA SC 009144
|
$351,735
|
$35,173
|
Levens, David
|
CCR (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$305,473
|
$30,547
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice
|
1R43CA235823-01
|
$300,000
|
$300,000
|
VARNUM, MEGAN
|
FIBROSIX, LLC
|
Total relevant funding to Hodgkins disease for this search: $13,282,652
|